All Articles

Dasher Neuroscience completes Phase 2 enrollment for its AI-designed drug for MSA, a fatal disease with no cure, signaling a major step toward a first-in-class therapy.

Futuri's Content Automation boasts an 80% cut in production time. As AI enters the newsroom, it forces a critical look at the future of journalism itself.

With $21M in funding and a novel 'lineage-based' approach, CORE Biomedicine is moving beyond genomics to target the root cause of cancer's identity.

A new partnership between FordDirect and Dealer Pay is more than a vendor deal. It’s a blueprint for modernizing the car-buying journey for millions.

The shift to usage-based pricing is seductive, but scaling it is treacherous. A new guide reveals why back-office operations are the real key to growth.

A new report reveals a hidden crisis: millions of working Americans are food insecure but earn too much for aid. This isn't a charity case; it's a systemic flaw.

NextPlat declares a strategic turnaround, but the real story is its complex model: blending high-margin healthcare with niche satellite tech. Can it deliver?

Nauticus Robotics' new AI-driven electric manipulator promises to slash costs and boost efficiency, signaling a major shift for the subsea industry.

The addition of a top international tax expert is more than a personnel move; it's the first major signal of how TPG's capital is arming Smith + Howard for a national expansion.

Parlance is upgrading healthcare IVR with advanced AI, enhancing patient calls without forcing costly system replacements. Here's why this strategy matters.

While giants chase scale, one firm's deep specialization in P&C insurance is earning top marks for both innovation and client experience. Here's why.

With a $100M war chest from a private Asian backer, AIOTF Software aims to become the Constellation Software of AI. Is this Canada's next tech giant?

Guardian Capital's new fund deploys AI to analyze the AI sector, offering a dynamic alternative to static ETFs for investors chasing the tech megatrend.

Interbrand and Clootrack's new AI platform transforms brand management from a periodic report into a live operating system, connecting every customer whisper to C-suite strategy.

AMD's massive deal with Core Scientific reveals a new front in the AI war: infrastructure. Securing gigawatts of power signals a strategic shift beyond silicon.

Everseen's acquisition of Viztel merges checkout security with full-store analytics, creating a single AI platform poised to redefine retail operations.

Two small firms just secured a patent until 2045 on a decades-old drug. It's a masterclass in strategy, revealing the future of pharmaceutical value.

New drilling at the Shovelnose project confirms thick, high-grade gold, including a record 200 g/t hit, as a major funding deal accelerates its path to production.

With two blockbuster cancer drugs driving revenue, Syndax's upcoming Q2 report is a critical test of its path to profitability and ambitious pipeline.

As DoubleDown Interactive preps its Q2 report, all eyes are on its European growth engine and a looming take-private offer from its parent company.